Atlas Trials

Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT07477912 · RECRUITING

Trial details

NCT number
NCT07477912
Sponsor
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma Refractory
Start date
2025-02-01
Primary completion
2028-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.